Cargando…

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma

SIMPLE SUMMARY: Neuroblastoma (NB) is the most common extra-cranial solid paediatric cancer and is responsible for 15% of childhood cancer deaths. Patients with NB are characterized by presenting a very heterogeneous clinic (inter-tumoural heterogeneity) and also both spatial and temporal intra-tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Carrasco, Amparo, Berbegall, Ana P., Martín-Vañó, Susana, Blanquer-Maceiras, Maite, Castel, Victoria, Navarro, Samuel, Noguera, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534138/ https://www.ncbi.nlm.nih.gov/pubmed/34680323 http://dx.doi.org/10.3390/cancers13205173

Ejemplares similares

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
por: López-Carrasco, Amparo, et al.
Publicado: (2020)

Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes
por: Fernández-Blanco, Beatriz, et al.
Publicado: (2020)

Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion
por: Villamón, Eva, et al.
Publicado: (2013)

High Oct4 expression: implications in the pathogenesis of neuroblastic tumours
por: Monferrer, Ezequiel, et al.
Publicado: (2019)

Neuroblastoma after Childhood: Prognostic Relevance of Segmental Chromosome Aberrations, ATRX Protein Status, and Immune Cell Infiltration()
por: Berbegall, Ana P., et al.
Publicado: (2014)

Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort
por: Tadeo, Irene, et al.
Publicado: (2016)

Digital Image Analysis Applied to Tumor Cell Proliferation, Aggressiveness, and Migration-Related Protein Synthesis in Neuroblastoma 3D Models
por: Monferrer, Ezequiel, et al.
Publicado: (2020)

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
por: Berbegall, Ana P., et al.
Publicado: (2018)

How to minimise the effect of tumour cell content in detection of aberrant genetic markers in neuroblastoma
por: Piqueras, M, et al.
Publicado: (2011)

Lymph microvascularization as a prognostic indicator in neuroblastoma
por: Tadeo, Irene, et al.
Publicado: (2018)

Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours
por: Braekeveldt, Noémie, et al.
Publicado: (2015)

A three-dimensional bioprinted model to evaluate the effect of stiffness on neuroblastoma cell cluster dynamics and behavior
por: Monferrer, Ezequiel, et al.
Publicado: (2020)

Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors
por: Tadeo, Irene, et al.
Publicado: (2016)

Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma
por: Burgos-Panadero, Rebeca, et al.
Publicado: (2019)

The prognostic value of (18)F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients
por: Liu, Jun, et al.
Publicado: (2022)

Phylogenetic Quantification of Intra-tumour Heterogeneity
por: Schwarz, Roland F., et al.
Publicado: (2014)

The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer‐aided detection
por: Vicente‐Munuera, Pablo, et al.
Publicado: (2019)

Two independent epigenetic biomarkers predict survival in neuroblastoma
por: Yáñez, Yania, et al.
Publicado: (2015)

Heterogeneity of neuroblastoma
por: Ngan, Elly Sau-Wai
Publicado: (2015)

Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer
por: Jones, Huw Geraint, et al.
Publicado: (2017)

Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages
por: J Ribelles, Antonio, et al.
Publicado: (2019)

The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma
por: Bogen, Dominik, et al.
Publicado: (2016)

Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages
por: Juan Ribelles, Antonio, et al.
Publicado: (2020)

Multi‐omics analysis of intra‐tumoural and inter‐tumoural heterogeneity in pancreatic ductal adenocarcinoma
por: Liu, Xiaoqian, et al.
Publicado: (2022)

Exosomes from N-Myc amplified neuroblastoma cells induce migration and confer chemoresistance to non-N-Myc amplified cells: implications of intra-tumour heterogeneity
por: Fonseka, Pamali, et al.
Publicado: (2019)

Biotensegrity of the Extracellular Matrix: Physiology, Dynamic Mechanical Balance, and Implications in Oncology and Mechanotherapy
por: Tadeo, Irene, et al.
Publicado: (2014)

Dissecting Intra-Tumor Heterogeneity by the Analysis of Copy Number Variations in Single Cells: The Neuroblastoma Case Study
por: Cariati, Federica, et al.
Publicado: (2019)

Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer
por: Cooke, S L, et al.
Publicado: (2011)

Catch my drift? Making sense of genomic intra-tumour heterogeneity()()
por: Sottoriva, Andrea, et al.
Publicado: (2017)

SMITH: spatially constrained stochastic model for simulation of intra-tumour heterogeneity
por: Streck, Adam, et al.
Publicado: (2023)

Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019)

Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models
por: Shembrey, Carolyn, et al.
Publicado: (2022)

Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.
por: Wilson, M. S., et al.
Publicado: (1993)

The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma
por: Zhai, Weiwei, et al.
Publicado: (2017)

Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer
por: Feng, Wanjing, et al.
Publicado: (2020)

TIAM1 variants improve clinical outcome in neuroblastoma
por: Sanmartín, Elena, et al.
Publicado: (2017)

Genetic heterogeneity and clonal evolution in neuroblastoma
por: Mora, J, et al.
Publicado: (2001)

Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
por: Lundberg, Kristina Ihrmark, et al.
Publicado: (2022)

Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
por: Stühler, Viktoria, et al.
Publicado: (2016)

Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces
por: Sangaletti, Sabina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_srq7dmvrimbp9lkp8v9khr1pgp